Answers are grounded in this paper and cite their sources.
Observational analysis reveals MMP-9 dysregulation and mineral deficiencies in patients with paranoid schizophrenia, indicating potential targets for therapy.
Neuroplastic disorder caused by dysregulation of matrix metalloproteinase-9 (MMP-9) is one of the leading mechanisms of pathogenesis of schizophrenia. This zinc and calcium-dependent enzyme is involved in the degradation of the extracellular matrix (ECM), and its hyperactivation leads to disruption of synaptic plasticity and neuronal architectonic. Excessive MMR-9 activity can be a result of macro and trace elements, including magnesium deficiency, which impairs ECM elasticity due to the effect on collagen synthesis. At the same time, zinc and calcium imbalance change the catabolic and stabilizing function of the enzyme. Violation of mineral homeostasis in patients with schizophrenia, especially with its prolonged course, correlates with a decrease in BDNF, deterioration of neurogenesis, and cognitive deficits. These neurobiochemical changes form the pathogenetic axis of "metalloproteinase - ECM - cognition". The purpose of this study was to establish the relationship between the MMP-9 concentration, the level of different micro and macroelements, and the duration of paranoid schizophrenia in order to identify potential biomarkers of disease progression and promising targets of personalized therapy. 320 people were examined, including 300 patients with a diagnosis of paranoid schizophrenia, divided into 5 subgroups depending on the duration of the disease, and 20 people with a primary psychotic episode (comparison group). All patients have evaluated the severity of psychopathological manifestations on the PANSS scale, as well as laboratory tests of MMP-9 levels in serum (ELISA) and content of zinc (Zn), copper (Cu), magnesium (Mg), calcium (Ca), and selenium (Se) in erythrocytes (AAS-method). Patients with paranoid schizophrenia have a significant decrease in the levels of zinc, cuprum, magnesium, calcium and selenium in erythrocytes, which correlates with the duration of the disease (p <0.05). The most significant deficits were recorded relative to selenium (up to –84.34 %), copper (–76.16 %) and zinc (–60.96 %). At the same time, there is an increase in the level of matrix metalproteinase-9 (MMP-9), which also progresses with increasing duration of the disease. The combination of SE, Zn and Mg deficiency with MMP-9 hyperexpression indicates a single pathogenetic cascade associated with oxidative stress, inflammation and neuroplastic disruption. The data obtained emphasize the key role of the imbalance of the trace elements and activation of MMP-9 in neurodegenerative processes that underlie the progression of psychotic disorder. The detected pattern of disorders suggests the existence of a pathogenetic cascade, in which the deficiency of trace elements, the growing activity of MMR-9, and ECM degradation contribute to the dysfunction of neuronal networks, reducing neuroplasticity and the development of cognitive deficiency. Thus, the study confirmed that the dysregulation of the activity of the matrix metalloproteinase-9 (MMP-9) in combination with dyselementhosis forms a pathogenetic cascade, within which there are significant disorders of neuroplasticity, which are implemented through the destruction of the ECM. Given the identified biochemical interconnections, these mechanisms can be considered as potential biomarkers of early diagnosis and promising therapeutic goals for a personalized approach to the treatment of patients with paranoid schizophrenia.
No takes yet. Share an insight, caveat, or question.
Ivan Romash (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: